Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D analogs and coactivators.

Guy Eelen1, Lieve Verlinden, Pierre De Clercq

  • 1Laboratorium voor Experimentele Geneeskunde en Endocrinologie, Katholieke Universiteit Leuven, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.

Anticancer Research
|August 5, 2006
PubMed
Summary

Structural analogs of 1alpha,25-dihydroxyvitamin D3 show promise for cancer treatment by reducing cell proliferation without causing hypercalcemia. This review explores their molecular mechanisms and interaction with the vitamin D receptor.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in bone characteristics precede serum mineral deterioration in a mouse model of early stage chronic kidney disease.

JBMR plus·2026
Same author

25-nitro-20-epi-vitamin D analogue with anti-proliferative and cytoprotective properties: Biological and pharmacological evaluation.

Experimental and molecular pathology·2026
Same author

Inducible kidney-selective knockdown of Cyp27b1 does not compromise calcium and bone homeostasis.

Journal of endocrinological investigation·2026
Same author

Author Correction: PHGDH heterogeneity potentiates cancer cell dissemination and metastasis.

Nature·2026
Same author

A novel model to study the impact of gender-affirming therapy on bone in young male mice.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Synthesis and biological evaluation of novel C1 or C3 amino derivatives of A-ring 1,2,3-trisubstituted 19-nor-vitamin D<sub>3</sub>.

Bioorganic & medicinal chemistry·2025

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • 1alpha,25-dihydroxyvitamin D3 (1,25-(OH)2D3) exhibits significant antiproliferative and prodifferentiating effects on various cell types, including cancer cells.
  • The therapeutic use of 1,25-(OH)2D3 is limited by its potent calcemic effects, which can lead to hypercalcemia.

Purpose of the Study:

  • To review the molecular mechanisms of action of novel 1,25-(OH)2D3 analogs.
  • To investigate the dissociation between antiproliferative and calcemic effects of these analogs.
  • To focus on the recruitment of cofactor molecules to the vitamin D receptor by different 1,25-(OH)2D3 analogs.

Main Methods:

  • Review of existing literature on 1,25-(OH)2D3 analogs.
  • Analysis of molecular mechanisms of action.

Related Experiment Videos

  • Examination of cofactor recruitment to the vitamin D receptor.

    • Main Results:

    • Structural analogs of 1,25-(OH)2D3 have been developed to separate antiproliferative and calcemic activities.
    • These analogs modulate the vitamin D receptor's interaction with cofactor molecules.
    • The specific molecular interactions influence the therapeutic potential for hyperproliferative disorders.

    Conclusions:

    • 1,25-(OH)2D3 analogs offer a promising therapeutic strategy for cancer and other hyperproliferative diseases.
    • Understanding the molecular interactions, particularly cofactor recruitment, is crucial for designing effective and safe vitamin D analogs.
    • Further research into these analogs could lead to novel cancer treatments with reduced side effects.